TCL Archive In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution July 16, 1982
TCL Archive Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020 January 28, 2011
TCL Archive Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare April 5, 2013
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
